This week, one of my patient advocacy highlights was to be part of an esteemed panel on an extremely important topic on “Impact of Patient Advocacy in Modern Healthcare Delivery Mechanisms” at the IHW Council event of ‘Patient First Summit & Awards 2022‘.
It was a great discussion to share with established and budding patient support groups & advocates who have attended this event on – how patient advocacy has potential to move mountains, how it is already changing the face of India healthcare system for better and why we need more patient advocacy in India. And top of that, awarding those amazing patient advocates/ advocacy groups, who are selflessly serving patients in India.
I am honored to contribute along with world leading experts on this extremely important ๐ฉ๐๐ฉ๐๐ซ on ๐๐๐ง๐๐๐ซ ๐๐๐ฌ๐๐๐ซ๐๐ก in ๐๐๐๐๐ฌ which got published in one the worldโs top journal โ๐๐๐ญ๐ฎ๐ซ๐ ๐๐๐๐ข๐๐ข๐ง๐ (impact factor: 53.44)โ. I have co-authored this paper along with: – Tata Memorial Centre, Homi Bhabha National Institute, India, – The Chief Scientist of WHO – and Scientists and leading experts from: > National Cancer Institute (NCI), USA > University of Oxford, England > University of Harvard, USA > Kingโs College London, > Queenโs University, Canada > University of Toronto, > University of North Carolina, USA > National Cancer Institute of Sri Lanka. > and scientists, researchers and oncologists from Turkey, Nepal, Kenya, Uganda, Malaysia, Ghana and France
This perspective paper is expected to be the ๐ ๐ฎ๐ข๐๐ข๐ง๐ ๐๐จ๐๐ฎ๐ฆ๐๐ง๐ญ in ๐ฉ๐จ๐ฅ๐ข๐๐ฒ ๐ฆ๐๐ค๐ข๐ง๐ as path forward for Cancer Research globally, including with LMICs.
I, being the only patient advocate across the globe, as part of this initiative – it was great opportunity to work with best of minds and world leading experts for better future of our patients and cancer research, globally.
Snapshot of the article is attached and link of the full article is as https://www.nature.com/articles/s41591-022-01738-xย . Hope you connect with this article and be part of this initiative so no one (including in LMICs) left alone and everyone has access and benefits of Cancer research.
Rise To Survive Cancer 